Alcoholic liver disease: treatment

Area of Science:

• Hepatology
• Gastroenterology
• Public Health

Background:

• Excessive alcohol intake is a primary cause of alcoholic liver diseases (ALD).
• ALD encompasses a spectrum from fatty liver to hepatocellular carcinoma, posing a substantial burden.
• Diagnosis relies on clinical history, liver disease indicators, and lab results.

Purpose of the Study:

• To review the spectrum, diagnosis, and current treatment strategies for alcoholic liver diseases.
• To highlight the importance of abstinence and available therapeutic options.
• To note ongoing research into novel therapeutic targets for ALD.

Main Methods:

• Literature review of ALD diagnosis and treatment guidelines.
• Synthesis of information on clinical features, laboratory findings, and disease progression.
• Overview of current therapeutic interventions and emerging research.

Main Results:

• ALD diagnosis is multifactorial, combining alcohol history, clinical signs, and biochemical data.
• Abstinence is the cornerstone of ALD management.
• Treatment plans are stratified by disease stage, with corticosteroids or pentoxifylline for severe alcoholic hepatitis.

Conclusions:

• Alcoholic liver diseases represent a complex health challenge requiring comprehensive management.
• Current treatments emphasize abstinence and stage-specific interventions.
• Further research is crucial for developing new therapies to combat ALD.